ArticleInvestigational new drugs2024

Phase I study of trifluridine/tipiracil (TAS-102) plus irinotecan in combination with bevacizumab as a second-line therapy for patients with metastatic colorectal cancer.

Jing Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.